Antibody Panel for the Detection of Aurora Kinase Family: Aurora A / STK15 / ARK1, Aurora B / STK12 / ARK2 and Aurora C / STK13 / AIK3
Chromosomal segregation during mitosis as well as meiosis is regulated by kinases and phosphatases. The Aurora kinases associate with microtubules during chromosome movement and segregation. Aurora kinase B localizes to microtubules near kinetochores, specifically to the specialized microtubules called K-fibers, and Aurora kinase A localizes to centrosomes.
Zhou et al. (1998) found that STK15 is involved in the induction of centrosome duplication-distribution abnormalities and aneuploidy in mammalian cells. Centrosomes appear to maintain genomic stability through the establishment of bipolar spindles during cell division, ensuring equal segregation of replicated chromosomes to 2 daughter cells. Deregulated duplication and distribution of centrosomes are implicated in chromosome segregation abnormalities, leading to aneuploidy seen in many cancer cell types. In addition amplification of STK15 could be demonstrated in approximately 12% of primary breast tumors, as well as in breast, ovarian, colon, prostate, neuroblastoma, and cervical cancer cell lines. High expression of STK15 mRNA was detected in tumor cell lines without evidence of gene amplification. Ectopic expression of STK15 in mouse NIH 3T3 cells led to the appearance of abnormal centrosome number (amplification) and transformation in vitro. Finally, overexpression of STK15 in near-diploid human breast epithelial cells revealed similar centrosome abnormality, as well as induction of aneuploidy. Aurora kinase A is a key regulatory component of the p53 pathway and overexpression of aurora kinase A leads to increased degradation of p53, causing downregulation of checkpoint-response pathways and facilitating oncogenic transformation of cells. These findings suggested that STK15 is a critical kinase-encoding gene, whose overexpression leads to centrosome amplification, chromosomal instability, and transformation in mammalian cells.
Aurora Kinase B is a Ser/Thr protein kinase member of the Aurora subfamily that may be directly involved in regulating the cleavage of polar spindle microtubules and is a key regulator for the onset of cytokinesis during mitosis. Aurora Kinase B is localized to the midzone of central spindle in late anaphase and concentrated into the midbody in telophase and cytokinesis and is colocalized with gamma tubulin in the mid-body. High levels of Aurora B expression are seen in the thymus, although it is also expressed in the spleen, lung, testis, colon, placenta and fetal liver. Aurora B is expressed during S and G2/M phase and expression is up-regulated in cancer cells during M phase.
Figure shows a model of Aurora B, INCENP, and Survivin interactions and regulation. Survivin binds the N-terminus of INCENP, whereas the N terminus of Aurora B binds the C-terminus of INCENP
Human Aurora Kinase C (AURKC, STK13) acts as a chromosomal passenger protein and forms complexes with AURKB and INCENP. AURKC phosphorylated histone H3 in vitro. INCENP bound and activated AURKC in vivo and in vitro, and AURKC coexpressed with INCENP elicited histone H3 phosphorylation of interphase cells. Using an in vitro kinase assay, Yan et al. (2005) found that AURKC-SV could phosphorylate a test substrate protein, and its activity depended on thr179. During cell mitosis, AURKC-SV associated with chromosomes in prophase and metaphase, and then transferred to the central spindle midzone and the cortex where the contracting ring formed during the transition from anaphase to telophase. It remained in the midbody during cytokinesis.
Antibody Panel to Aurora Kinase Subfamily (Aurora A / STK15 antibody, Aurora B / STK12 antibody, Aurora C / STK13 antibody)
Acris Antibodies offers a collection of polyclonal and monoclonal antibodies to members of the Aurora kinase family (Aurora A / STK15 antibody, Aurora B / STK12 antibody, Aurora C / STK13 antibody). These antibodies are usefull for detection of Aurora Kinases. These antibodies are suitable for Western blotting and immunohistochemistry methods, but also other immunological applications, like immunocytochemistry and immunoprecipitation.
Fig.1: Panel A. Extracts from untreated Hela cells (Lane 1) or overnight nocodazole-treated Hela cells (Lane 2) were immunoprecipitated with a pan-Aurora A monoclonal antibody (clone 35C1, NB100-1641), resolved by electrophoresis, transferred to nitrocellulose and probed with rabbit polyclonal antibody against Thr288 phosphorylated Aurora A NB600-1157. Proteins were visualized using a donkey anti-rabbit secondary conjugated to HRP and a chemiluminescence detection system. |
Fig.2: Panel B. The blot shown in Panel A was stripped and re-probed with pan-Aurora specific polyclonal antibody to verify equal loading of Aurora A in the extracts. Proteins were visualized using a donkey anti-rabbit secondary conjugated to HRP and a chemiluminescence detection system. |
Fig.3: Detection of Human Phospho-Aurora A (T288) by Immunocytochemistry. Samples: NBF-fixed asynchronous HeLa cells. Antibody: Affinity purified rabbit anti-Phospho- Aurora A (T288) (NB 100-2371) used at a dilution of 1:250. Detection: Anti-rabbit IgG-FITC conjugated (NB 7159) used at a dilution of 1:100. |
Fig.4: Detection of Human Phospho-Aurora A (T288) by Immunocytochemistry. Samples: NBF-fixed asynchronous HeLa cells. Mock phosphatase treated section (left) or calf intestinal phosphatase-treated section (right) immunostained for Phospho-Aurora A. Antibody: Affinity purified rabbit anti- Phospho-Aurora A (T288) (NB 100-2371) used at a dilution of 1:250. Detection: Anti-rabbit IgG-FITC conjugated (NB 7159) used at a dilution of 1:100. |
Fig.5: Detection of rat Aurora A in mammary gland whole cell tissue lysate (60 ug) using NB 100-635. 6 minute ECL exposure time. *Note: The upper band is believed to be phosphorylated Aurora A. |
Fig.6: Immunofluorescent localization of mouse Aurora A to centrosomes of a mammary epithelial cell line using NB 100-635. Detection by Alexa 488 labeled gaot anti-Rabbit IgG (green) and DAPI (blue). |
Fig.7: Detection of Human Aurora B by Immunohistochemistry. Sample: FFPE section of human colon adenocarcinoma. Antibody: Affinity purified rabbit anti-Aurora B NB 100-1729 used at a dilution of 1:100. Detection: DAB |
Available antibodies to Aurora Kinases
Aurora A antibodies ( STK15 antibody, ARK1 antibody ), Aurora B antibodies ( STK12 antibody, ARK2 antibody ), Aurora C antibodies ( STK13 antibody, AIK3 antibody ) and Aurora A/B antibodies ( STK 12/15 antibody, ARK 1/2 antibody )
54 related products - click here to filter product result list
Antibodies
| Catalog No. | Clone/Isotype | Presentation | Reactivity | Applications | ||
|---|---|---|---|---|---|---|
| H00006790-A01 | Aurora-A / STK15 / ARK1 antibody | |||||
| - | Serum | 50 µl / --- | ||||
| Mouse | Abnova Taiwan Corp. | |||||
| H00006790-M01 | Aurora-A / STK15 / ARK1 antibody | |||||
| 5F8 | Purified | 100 µg / --- | ||||
| Mouse | IgG | Abnova Taiwan Corp. | ||||
| SM2084B | Aurora-A / STK15 / ARK1 antibody | |||||
| 35C1 | Biotin | 0.1 mg / US$ 525 | ||||
| Mouse | IgG2b | Acris Antibodies GmbH | ||||
| SM2084P | Aurora-A / STK15 / ARK1 antibody | |||||
| 35C1 | Purified | 0.1 mg / US$ 495 | ||||
| Mouse | IgG2b | Acris Antibodies GmbH | ||||
| SP2058P | Aurora-A / STK15 / ARK1 antibody | |||||
| - | Aff - Purified | 50 µg / US$ 405 | ||||
| Rabbit | Acris Antibodies GmbH | |||||
| EB05035 | Aurora-A / STK15 / ARK1 antibody | |||||
| - | Aff - Purified | 0.1 mg / --- | ||||
| Goat | Everest Biotech Ltd. | |||||
| GTX12324 | Aurora-A / STK15 / ARK1 antibody | |||||
| Aff - Purified | 50 µg / --- | |||||
| Rabbit | IgG | GeneTex Inc. | ||||
| GTX13408 | Aurora-A / STK15 / ARK1 antibody | |||||
| Purified | 50 µg / --- | |||||
| Rabbit | IgG | GeneTex Inc. | ||||
| GTX13824 | Aurora-A / STK15 / ARK1 antibody | |||||
| 35C1 | Ig Fraction | 100 µl / --- | ||||
| Mouse | IgG2b | GeneTex Inc. | ||||
| GTX16596 | Aurora-A / STK15 / ARK1 antibody | |||||
| 100 µg / --- | ||||||
| Rabbit | IgG | GeneTex Inc. | ||||
| GTX21287 | Aurora-A / STK15 / ARK1 antibody | |||||
| Aff - Purified | 50 µg / --- | |||||
| Rabbit | IgG | GeneTex Inc. | ||||
| GTX29689 | Aurora-A / STK15 / ARK1 antibody | |||||
| Ig Fraction | 100 µg / --- | |||||
| Goat | IgG | GeneTex Inc. | ||||
| GTX30367 | Aurora-A / STK15 / ARK1 antibody | |||||
| Aff - Purified | 100 µg / --- | |||||
| Rabbit | GeneTex Inc. | |||||
| GTX77628 | Aurora-A / STK15 / ARK1 antibody | |||||
| Purified | 50 µg / --- | |||||
| Rabbit | IgG | GeneTex Inc. | ||||
| NB100-1641 | Aurora-A / STK15 / ARK1 antibody | |||||
| 35C1 | Purified | 50 µl / US$ 485 | ||||
| Mouse | IgG2b | Novus Biologicals Inc. | ||||
| NB100-1829 | Aurora-A / STK15 / ARK1 antibody | |||||
| 35C1 | Biotin | 50 µl / US$ 505 | ||||
| Mouse | IgG2b | Novus Biologicals Inc. | ||||
| NB100-212 | Aurora-A / STK15 / ARK1 antibody | |||||
| - | Aff - Purified | 0.1 ml / US$ 495 | ||||
| Rabbit | Novus Biologicals Inc. | |||||
| NB100-267 | Aurora-A / STK15 / ARK1 antibody | |||||
| - | Aff - Purified | 0.1 mg / US$ 485 | ||||
| Rabbit | Novus Biologicals Inc. | |||||
| NB100-635 | Aurora-A / STK15 / ARK1 antibody | |||||
| - | Aff - Purified | 0.1 mg / US$ 505 | ||||
| Rabbit | Novus Biologicals Inc. | |||||
| NB100-917 | Aurora-A / STK15 / ARK1 antibody | |||||
| Aff - Purified | 3 x 0.1 ml / ask | |||||
| Rabbit | Novus Biologicals Inc. | |||||
| NB600-435 | Aurora-A / STK15 / ARK1 antibody | |||||
| - | Agarose | 0.4 ml / US$ 485 | ||||
| Rabbit | Novus Biologicals Inc. | |||||
| 10297-1-AP | Aurora-A / STK15 / ARK1 antibody | |||||
| Aff - Purified | 150 µl / --- | |||||
| Rabbit | IgG | ProteinTech Group, Inc. | ||||
| NB110-55479 | Aurora-A / STK15 / ARK1 (C-term) antibody | |||||
| EP1008Y | Purified | 0.1 ml / US$ 485 | ||||
| Rabbit | IgG | Novus Biologicals Inc. | ||||
| 13040 | Aurora-A / STK15 / ARK1 (exon 5) antibody | |||||
| - | Aff - Purified | 0.1 mg / --- | ||||
| Rabbit | QED Bioscience Inc. | |||||
| 13042 | Aurora-A / STK15 / ARK1 (exons 5, 6) antibody | |||||
| - | Aff - Purified | 0.1 mg / --- | ||||
| Rabbit | QED Bioscience Inc. | |||||
| NB100-2371 | Aurora-A / STK15 / ARK1 (pThr288) antibody | |||||
| - | Purified | 0.1 ml / US$ 575 | ||||
| Rabbit | Novus Biologicals Inc. | |||||
| NB600-1157 | Aurora-A / STK15 / ARK1 (pThr288) antibody | |||||
| - | Purified | 0.1 ml / US$ 515 | ||||
| Rabbit | Novus Biologicals Inc. | |||||
| SP7343P | Aurora-A/B / STK12/15 / ARK1/2 antibody | |||||
| - | Purified | 0.1 mg / US$ 405 | ||||
| Rabbit | Acris Antibodies GmbH | |||||
| H00009212-M01 | Aurora-B / STK12 / ARK2 antibody | |||||
| 6A6 | Purified | 100 µg / --- | ||||
| Mouse | IgG | Abnova Taiwan Corp. | ||||
| H00009212-M03 | Aurora-B / STK12 / ARK2 antibody | |||||
| 6H7 | Purified | 100 µg / --- | ||||
| Mouse | IgG | Abnova Taiwan Corp. | ||||
| H00009212-M04 | Aurora-B / STK12 / ARK2 antibody | |||||
| 6G8 | Purified | 100 µg / --- | ||||
| Mouse | IgG | Abnova Taiwan Corp. | ||||
| BP4524 | Aurora-B / STK12 / ARK2 antibody | |||||
| - | Aff - Purified | 0.2 ml / US$ 515 | ||||
| Sheep | Acris Antibodies GmbH | |||||
| R1539P | Aurora-B / STK12 / ARK2 antibody | |||||
| - | Aff - Purified | 0.1 mg / US$ 465 | ||||
| Rabbit | Acris Antibodies GmbH | |||||
| NB100-1729 | Aurora-B / STK12 / ARK2 antibody | |||||
| Aff - Purified | 0.1 ml / US$ 565 | |||||
| Rabbit | Novus Biologicals Inc. | |||||
| NB100-294 | Aurora-B / STK12 / ARK2 antibody | |||||
| - | Purified | 0.1 ml / US$ 435 | ||||
| Rabbit | Novus Biologicals Inc. | |||||
| NB500-185 | Aurora-B / STK12 / ARK2 antibody | |||||
| - | Aff - Purified | 0.1 mg / ask | ||||
| Rabbit | Novus Biologicals Inc. | |||||
| 10792-1-AP | Aurora-B / STK12 / ARK2 antibody | |||||
| Aff - Purified | 150 µl / --- | |||||
| Rabbit | IgG | ProteinTech Group, Inc. | ||||
| 65031-1-Ig | Aurora-B / STK12 / ARK2 antibody | |||||
| Purified | 150 µl / --- | |||||
| Mouse | IgG1 | ProteinTech Group, Inc. | ||||
| NB110-55480 | Aurora-B / STK12 / ARK2 (N-term) antibody | |||||
| EP1009Y | Purified | 0.1 ml / US$ 515 | ||||
| Rabbit | IgG | Novus Biologicals Inc. | ||||
| A4190-17 | Aurora-C / STK13 / AIK3 antibody | |||||
| - | Aff - Purified | 40 µg / --- | ||||
| Rabbit | United States Biological | |||||
| NB110-55481 | Aurora-C / STK13 / AIK3 (N-Term) antibody | |||||
| EP1011Y | Purified | 0.1 ml / US$ 515 | ||||
| Rabbit | IgG | Novus Biologicals Inc. | ||||
Protein
| Catalog No. | Species | Presentation | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| H00006790-P01-02 | Aurora-A / STK15 / ARK1 antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00006790-P01-10 | Aurora-A / STK15 / ARK1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00006790-P01-25 | Aurora-A / STK15 / ARK1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00006790-Q01-10 | Aurora-A / STK15 / ARK1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00006790-Q01-25 | Aurora-A / STK15 / ARK1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00006790-Q02-10 | Aurora-A / STK15 / ARK1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00006790-Q02-25 | Aurora-A / STK15 / ARK1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009212-P01-10 | Aurora-B / STK12 / ARK2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009212-P01-25 | Aurora-B / STK12 / ARK2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009212-Q01-10 | Aurora-B / STK12 / ARK2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009212-Q01-25 | Aurora-B / STK12 / ARK2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00006795-Q01-10 | Aurora-C / STK13 / AIK3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00006795-Q01-25 | Aurora-C / STK13 / AIK3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||







